Investor Presentaiton

Our Manufacturing Footprint: 7 facilities - 6 in India and 1 in US 13 Installed capacity › 34,560 TPA > 4,800 TPA Value chain Facility location › Bonthapally › Jeedimetla ΑΡΙ > Vizag (Unit IV) > 380 KL ΑΡΙ > Vizag (Unit V) > 15 KL › Bonthapally II (API Intermediate) > 61.5 KL Approvals › U.S. FDA, EDQM, WHO, COFEPRIS, INFARMED › U.S. FDA, EDQM, COFEPRIS, WHO, CDCSO › U.S. FDA, KFDA, EU GMP, WHO GMP, EDQM › EU GMP PFI › Gagillapur > 23,200 TPA › US FDA, COFEPRIS, TGA, MCC, INFARMED PFI › Jeedimetla > 1,440 TPA > WHO GMP, COFEPRIS, INFARMED › Gagillapur > 26.8 Bn › US FDA, MCC, COFEPRIS, TGA, INFARMED FD > Virginia, USA > 1.5 Bn › US FDA, DEA > Vizag (Unit V) > 1.1 Bn › EU GMP 7

View entire presentation